Navigation Links
Particle Sciences Completes Development of First Product Incorporating its Unique Surface Modification System
Date:2/24/2009

BETHLEHEM, Pa., Feb. 24 /PRNewswire/ -- Particle Sciences Inc. today announced the development of a unique film-forming system with applications ranging from tissue hydration to the passivation of medical device surfaces. "The backbone of the system is a series of patent-pending polymers that allow Particle Sciences to 'dial in' the desired contact angle," says Andrew Loxley, PS' Director of New Technologies.

Particle Sciences has already used the system to develop an ocular formulation for one of its clients. Early clinical results are very promising but are still embargoed. "In this application, we were able to achieve substantial improvement over existing products in terms of degree and duration of activity using this newly developed approach," says Robert Lee, PS' VP Pharmaceutical Development.

Dr. Lee adds that "This technology adds to the broad array of approaches Particle Sciences has to address our clients' needs. As formulations become increasingly challenging, Particle Sciences has positioned itself well with the development and acquisition of various technologies and capabilities focused on drug delivery."

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. For more information on Particle Sciences, visit www.particlesciences.com.

    Contact:
    Maureen Cochran
    mcochran@particlesciences.com
    610-861-4701


'/>"/>
SOURCE Particle Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
2. Anthrax vaccine produces immunity with nanoparticles, not needles
3. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
4. New DNA-based technique for assembly of nano- and micro-sized particles
5. New nanoparticle vaccine is more effective but less expensive
6. Anthrax vaccine produces immunity with nanoparticles, not needles
7. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
8. Researchers outline structure of largest nonvirus particle ever crystallized
9. DNA technique yields 3-D crystalline organization of nanoparticles
10. Strengthening fluids with nanoparticles
11. 2-faced particles act like tiny submarines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge Semantics , ... at this year’s Bio-IT World Conference and Expo in Boston May 23-25 ... 4.0 solution. The Anzo Smart Data Lake is also a finalist for the ...
(Date:5/21/2017)... ... May 19, 2017 , ... Ovation Fertility scientists’ ... American Association of Bioanalysts (AAB) and the College of Reproductive Biology (CRB) today ... AAB’s commitment to excellence in clinical laboratory services and regulations. , “We ...
(Date:5/18/2017)... (PRWEB) , ... May 18, 2017 , ... ... activities. The Tapas Cooking Challenge is a two-hour team-building package designed for ... menu created by Chef Jodi Abel, which include items, such as Blackened Shrimp ...
(Date:5/18/2017)... ... May 17, 2017 , ... USDM ... firm for the life sciences and healthcare industries, is honored that Jay ... Medical Devices conference in Brussels, Belgium. , Crowley played a crucial role in ...
Breaking Biology Technology:
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
Breaking Biology News(10 mins):